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Received July 29, 2013; accepted January 29, 2014AbstractBackground: This study investigated the effect of thiamine pyrophosphate (TPP) on oxidative liver damage induced in rats with high-dose
paracetamol.
Methods: Rats for this experiment were divided into the following groups: healthy control, paracetamol control, thiamine þ paracetamol,
TPP þ paracetamol, and N-acetylcysteine þ paracetamol. Oxidant and antioxidant parameters and liver function test levels were compared
between the groups.
Results: The results show that TPP and N-acetylcysteine with paracetamol equally prevented a rise in oxidants such as malondialdehyde and
nitric oxide. They also prevented a decrease in enzymatic and nonenzymatic antioxidants such as glutathione, glutathione peroxidase, gluta-
redoxin, glutathione S-transferase, superoxide dismutase, and catalase in the rat liver.
Conclusion: Thiamine pyrophosphate and N-acetylcysteine had a similar positive effect on oxidative damage caused by paracetamol hepato-
toxicity. These findings show that TPP may be beneficial in paracetamol hepatotoxicity.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Paracetamol is an effective para-aminophenol type anal-
gesic and antipyretic drug.1 A 150 mg/kg dose of paracetamol
has a high probability of toxic effects.2 According to United
States statistics, more than 100,000 cases of paracetamol
poisoning occur annually.3 Paracetamol poisoning occurs in
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paracetamol can lead to severe damage in the liver and to liver
failure.5 Because of this serious impact on the liver, the agent
is tested directly for the extent of hepatotoxicity.6 The hepa-
totoxic effect of paracetamol is associated with the toxic
metabolite N-acetyl-p-benzoquinoneimine (NAPB), which
forms in the liver.
This metabolite is detoxified by endogenous glutathione
(GSH). However, if paracetamol is taken in high doses, it de-
pletes GSH stores and leads to an inability to detoxify NAPB
sufficiently, which results in hepatic toxicity.7,8 A rise in lipid
peroxidation in paracetamol toxicity is reportedly associated
with a decrease in the antioxidant GSH.9 Nitric oxide (NO)
increases in paracetamol-associated hepatotoxicity, therebyociation. All rights reserved.
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stress is an important factor in liver toxicity caused by para-
cetamol.11 N-acetyl cysteine (NAC) is used in cases of para-
cetamol toxicity, although it does not represent a definitive
solution, and the condition may even require liver trans-
plantation.1 These data from the literature suggest that other
stress factors, as well as GSH, have a role in paracetamol
toxicity. Thiamine pyrophosphate (TPP) that we tested in this
study is an active metabolite of thiamine (TA). Thiamine py-
rophosphate is also a cofactor of the enzymes that have a role in
maintaining cell redox by synthesizing nicotinamide adenine
dinucleotide phosphate (NADPH) and glutathione.12 Several
drugs and substances reportedly prevent the conversion of TA
into TPP in the body.13e15 This suggests that the toxic effects of
drugs may be associated with the inhibition of TPP formation.
Our review of the literature revealed no data concerning the
use of TPP to inhibit paracetamol-induced hepatic damage.
The purpose of this study was therefore to investigate the ef-
fect of TPP on oxidative liver damage induced by paracetamol
in rats, and to compare this with the effects of TA and NAC.
2. Methods2.1. AnimalsThe animals in the experiment (male albino Wistar rats)
were obtained from the Ataturk University Medical Experi-
mental Practice and Research Center (Erzurum, Turkey).
Thirty rats weighing 225e240 g were randomly divided into
five groups before the experiment. They were housed and fed
in a normal laboratory environment (22C).2.2. Chemical substancesRegarding the chemical substances used for the experi-
ments, thiopental sodium was provided by I.E. Ulagay
(Istanbul, Turkey). Thiamine and TPP were obtained from
Biopharma (Moscow, Russia). N-acetylcysteine was obtained
from the Husnu Arsan Drug Company (Istanbul, Turkey) and
paracetamol was obtained from the Atabay Drug Company
(Istanbul, Turkey).2.3. Experimental protocolExperimental animals were divided into the healthy group
(HG), paracetamol control group (PAG), thiamine group
(TAG), thiamine pyrophosphate þ paracetamol group (TPPG),
and N-acetylcysteine þ paracetamol group (NACG). The TAG
group was injected intraperitoneally with 20 mg/kg TA
(n ¼ 6); the TPPG group, 20 mg/kg TPP (n ¼ 6); and the
NACG group (n ¼ 6), 300 mg/kg NAC. The HG (n ¼ 6) and
PAG (n ¼ 6) were administered distilled water by the
same route. One hour before the administration of drugs
and distilled water, paracetamol at a dose of 1000 mg/kg
was administered orally to all rat groups (excluding the
HG). The doses used in this study were selected on the basis
of our previous studies.16,17 Twenty-four hours after theadministration of paracetamol, all animals were sacrificed
under high-dose anesthesia. Their livers were removed and
biochemical investigations were performed. The biochemical
results from the TAG, TPPG, and NACG were compared to
those of the PAG and HG.2.4. Biochemical analyses
2.4.1. Specimen preparation
From each extracted liver, 0.2 g was weighed. The livers
were homogenized in 0.5% hexadecyltrimethylammonium
bromide containing 1.15% potassium chloride solution for the
malondialdehyde (MDA) assay and 7.5 pH phosphate buffer
for other measurements. This totaled 2 mL in an iced envi-
ronment. They were subsequently centrifuged at 15,320g for
15 minutes at 4C. The supernatant part was used as a spec-
imen for analysis. For all measurements, tissue-protein esti-
mation was performed using Bradford's method.18
2.4.2. Malondialdehyde assay
This assay was based on spectrophotometric measurement
at an emission wavelength of 532 nm of the absorbance of the
pink complex formed at a high temperature (95C) by thio-
barbituric acid and MDA.19
2.4.3. Nitric oxide assay
Nitric oxide levels were measured using the Griess reac-
tion,20,21 which is based on a two-step process. In the first step,
nitrate is converted into nitrite by nitrate reductase. In the
second step, nitrite reacts with the Griess reagent. At the end
of this reaction, a deep purple azo compound forms. The
absorbance of this azo compound was measured photometri-
cally at the 540 nm wavelength. This azo chromophore
accurately determines nitrite concentrations as a marker of
NO.
2.4.4. Total glutathione assay
5,50-Dithiobis-(2-nitrobenzoic acid) (DTNB) is a disulfide
chromogen easily reduced by sulfhydryl group compounds.
The resulting yellow color is measured spectrophometrically
at 412 nm.22
2.4.5. Glutathione peroxidase assay
Glutathione peroxidase (GPO) activity was determined by
the method described by Lawrence and Burk.23 After tissue
homogenization, the supernatant was used for GPO measure-
ment. The mixture was incubated after adding monopotassium
phosphate, EDTA, GSH, beta-NADPH, sodium azide, and
GRx. As soon as hydrogen peroxide (H2O2) was added, the
chronometer was turned on and the absorbance at 340 nm was
recorded every 15 seconds for 5 minutes.
2.4.6. Glutathione reductase assay
Glutathione reductase (GRx) activity was determined
spectrophotometrically by measuring the rate of NADPH
oxidation at 340 nm, based on Carlberg and Mannervik's
method.24 After tissue homogenization, the supernatant was
Fig. 1. A comparison of the groups, based on the level of MDA (mmol/g
protein), NO (mmol/g protein), GSH (nmol/g protein), and GPO (U/g protein).
The bars are the mean ± standard error of the mean. GPO ¼ glutathione
peroxidase; GSH ¼ glutathione; HG ¼ healthy group;
MDA ¼ malondialdehyde; NACG ¼ N-acetylcysteine þ paracetamol group;
NO ¼ nitric oxide; PAG ¼ paracetamol control group;
TAG ¼ thiamine þ paracetamol group; TPPG ¼ thiamine
pyrophosphate þ paracetamol group. * A value of p  0.05 is significant.
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glutathione disulfide (GSSG), the chronometer was turned on
and the absorbance was measured spectrophotometrically at
30-second intervals for 5 minutes at 340 nm.
2.4.7. Glutathione S-transferase activity assay
Glutathione S-transferase (GST) activity was determined
using the method described by Habig and Jakoby.25 In brief,
enzyme activity was assayed spectrophotometrically at
340 nm in a 4-mL cuvette containing 0.1 M phosphate buff-
ered saline (pH 6.5), 30 mM GSH, 30 mM 1-chloro-2,6-
dinitrobenzene, and tissue homogenate.
2.4.8. Superoxide dismutase assay
Measurements were performed by the method described by
Sun et al.26 Superoxide dismutase (SOD) forms when xanthine
oxidase converts xanthine into uric acid. If nitro blue tetra-
zolium (NBT) is added to this reaction, SOD reacts with NBT
and a purple formazan dye occurs. The absorbance of the
purple formazan dye was measured at 560 nm.
2.4.9. Catalase activity assay
Decomposition of H2O2 in the presence of catalase (CAT)
was measured at 240 nm.27 The CAT activity was defined as
the amount of enzyme required to process 1 nM H2O2 per
minute at 26C and pH 7.8.2.5. Analysis of liver function testsVenous blood samples were collected into tubes without an
anticoagulant. After clotting, the serum was separated by
centrifugation and stored at 80C until assay. Using a Cobas
8000 autoanalyzer (Roche Diagnostics GmBH, Mannheim,
Germany) with commercially available kits (Roche Di-
agnostics), serum aspartate aminotransferase (AST) and alanine
transaminase (ALT) activities were measured spectrophoto-
metrically for the liver function tests and lactate dehydrogenase
(LDH) activity was measured as a marker of tissue injury.2.6. Statistical analysisAll data were subjected to the Kruskal-Wallis test using
SPSS version 18.0 software (IBM Corporation, Armonk, NY,
USA). Differences between groups were obtained using Wil-
coxon rank sum tests with Bonferroni corrections. Significance
was declared at p  0.05. The results are expressed as the
mean ± the standard error of the mean (SEM).
3. Results3.1. MDA, NO, GSH, GPO, GRx, GST, SOD, and CAT
analysesSignificant differences between the groups were determined
in the parameters MDA, NO, GSH, GPO, GRx, GST, SOD,
and CAT ( p < 0.05). As Fig. 1 shows, MDA concentrations in
the liver tissue in the HG, TAG, TPPG, NACG, and PAG were2.2 ± 0.4 mmol/g protein ( p < 0.05), 9.2 ± 1.3 mmol/g protein
( p > 0.05), 3.5 ± 0.7 mmol/g protein ( p < 0.05),
2.8 ± 0.6 mmol/g protein ( p < 0.05), and 10.5 ± 0.8 mmol/g
protein, respectively. The NO levels were 5.7 ± 0.9 mmol/g
protein ( p < 0.05), 11.3 ± 0.9 mmol/g protein ( p > 0.05),
6.1 ± 0.7 mmol/g protein ( p < 0.05), 6.3 ± 0.8 mmol/g protein
( p < 0.05), and 12.5 ± 1.1 mmol/g protein, respectively
(Fig. 1). The GSH levels for these groups were 7.7 ± 0.8 nmol/
g protein for the HG ( p < 0.05), 2.0 ± 0.6 nmol/g protein for
the TAG, ( p > 0.05), 7.4 ± 0.5 nmol/g protein for the TPPG
( p < 0.05), 7.6 ± 0.6 nmol/g protein for the NACG ( p < 0.05),
and 1.6 ± 0.1 nmol/g protein for the PAG (Fig. 1). Glutathione
peroxidase activity in the HG and in the PAG was
13.3 ± 0.9 U/g protein ( p < 0.05) and 2.3 ± 0.4 U/g protein,
respectively. This activity in the liver tissues of the TAG,
TPPG, and NACG was 3.1 ± 0.5 U/g protein ( p > 0.05),
10.6 ± 0.9 U/g protein ( p < 0.05), and 12 ± 1 U/g protein
( p < 0.05), respectively (Fig. 1). As Table 1 shows, the GRx
and GST activity in the liver tissue was significantly higher in
the HG, TPPG, and NACG than in the TAG and PAG
( p < 0.05). The SOD and CAT activities were also signifi-
cantly higher in the HG, TPPG, and NACG than in the TAG
and PAG ( p < 0.05).3.2. AST, ALT, and LDH analysesAs Fig. 2 shows, the blood AST values in the HG, TAG,
TPPG, NACG, and PAG were 36.8 ± 4.8 U/L ( p < 0.05),
265.6 ± 9.8 U/L ( p > 0.05), 64 ± 4.5 U/L ( p < 0.05),
109.5 ± 2.8 U/L ( p < 0.05), and 274.1 ± 8.2 U/L, respectively.
The ALT levels in the blood specimens of the HG, TAG,
TPPG, NACG, and PAG were 15.1 ± 3.5 U/L ( p < 0.05),
150.8 ± 10.7 U/L ( p > 0.05), 32.6 ± 2.8 U/L ( p < 0.05),
55.6 ± 2.3 U/L ( p < 0.05), and 157.3 ± 13.3 U/L, respectively
(Fig. 2). As Fig. 3 shows, the LDH levels in the HG, TAG,
TPPG, NACG, and PAG were 157.3 ± 11 U/L ( p < 0.05),
543.3 ± 5.8 U/L ( p > 0.05), 199 ± 5.6 U/L ( p < 0.05),
285.2 ± 8.7 U/L ( p < 0.05), and 600 ± 12.6 U/L, respectively.
Table 1
Comparisons of groups, based on GRx, GST, SOD, and CAT activities.a
GRx (U/g protein) GST (U/g protein) SOD (mmol/min/mg tissue) CAT (mmol/min/mg tissue)
PAG
n ¼ 6









































All values are expressed as the mean ± standard error of the mean.
CAT ¼ catalase; GRx ¼ glutathione reductase; GST ¼ glutathione S-transpherase; HG ¼ healthy group; n ¼ number of animals; NACG ¼ N-
acetylcysteine þ paracetamol group; PAG ¼ paracetamol control group; SOD ¼ superoxide dismutase; TAG ¼ thiamine þ paracetamol group; TPPG ¼ thiamine
pyrophosphate þ paracetamol group.
*A p  0.05 was significant.
a A comparison of the activities of GRx, GST, SOD, CATof each group versus the control group, based on Wilcoxon rank sum tests with Bonferroni corrections.
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This study investigated the effect of TPP on oxidative liver
damage induced in rats with high-dose paracetamol. This study
also evaluated TPP in comparison with TA and NAC.
Mammalian peroxisomes contain TPP; however, no pyrophos-
phorylation of thiamine occurs in these organelles, which sug-
gests that TPP is already pyrophosphorylated when it enters the
peroxisome.28,29 The entry of TPP into the cell is not fully un-
derstood. However, it may depend on a specific transport system
or (in a bound form) on 2-hydroxyacyl-CoA lyase 1 trans-
location.28 We therefore examined the effect of TPP and of TZ,
and compared this with NAC. The results showed that paracet-
amol administered orally at a dose of 1000 mg/kg led to pro-
nounced oxidative stress in the liver. Under physiological
conditions, the oxidant/antioxidant balance is maintained in
favor of antioxidants. A compromise of this balance leads to
tissue damage (i.e., oxidative stress). Tissue damage is evaluated
through the oxidant/antioxidant balance. This balance alters in
favor of antioxidants in various models of damage in living
tissues: a rise in oxidant levels and a decrease in antioxidant
levels occurs.30 Our results are compatible with these data from
the literature. In the experiment, the level of MDA (an oxidantFig. 2. A comparison of groups, based on AST and ALT activity. The bars are
the mean ± standard error of the mean. ALT ¼ alanine transaminase;
AST ¼ aspartate aminotransferase; HG ¼ healthy group; NACG ¼ N-
acetylcysteine þ paracetamol group; PAG ¼ paracetamol control;
TAG ¼ thiamine þ paracetamol; TPPG ¼ thiamine
pyrophosphate þ paracetamol. * A value of p  0.05 was significant.parameter) in the rat groups receiving TPP and NAC decreased,
compared to the level in the PAG. A rise in MDA levels in a
tissue shows that free oxygen radicals have increased in that
tissue. A rise in free oxygen radicals increases lipid peroxida-
tion. Malondialdehyde is a product of lipid peroxidation and
leads to cell damage by causing cell membrane compounds to
cross-link.31,32 Studies show that the level of MDA rises in he-
patic oxidative damage.33
Nitric oxide is another factor leading to lipid peroxidation.
It also reportedly initiates lipid peroxidation in an environment
containing superoxide.34 Excess NO production in the liver
therefore leads to hepatic damage.35 The finding that the NO
levels in the rat liver tissue is lower in the TPPG and the
NACG than in the PAG indicates that paracetamol causes
oxidative stress in the rat liver, which is inactivated and pre-
vented to a significant extent by TPP and NAC.
Excessive doses of paracetamol reportedly increase lipid
peroxidation by raising GSH.9 The hepatotoxic effect of
paracetamol may be via its metabolite NAPB. This toxic
metabolite is detoxified by endogenous GSH. However, when
paracetamol is administered in toxic doses, excessive NAPB
forms and cannot be sufficiently detoxified by GSH. The
production of NAPB in amounts that exceed the detoxifyingFig. 3. A comparison of the groups, based on LDH activity. The bars are the
mean ± standard error of the mean. HG ¼ healthy group; LDH ¼ lactate
dehydrogenase; NACG ¼ N-acetylcysteine þ paracetamol group;
PAG ¼ paracetamol control group; TAG ¼ thiamine þ paracetamol group;
TPPG ¼ thiamine pyrophosphate þ paracetamol group. * A value of p  0.05
is significant.
467A. Kisaoglu et al. / Journal of the Chinese Medical Association 77 (2014) 463e468capacity of GSH also results in liver toxicity.36,37 These data
from the literature agree with our own findings. Glutathione is
an endogenous antioxidant molecule. In addition to GSH,
enzymatic antioxidants such as GPO, GRx, GST, SOD, and
CAT protect cells against free oxygen radical damage.38 A
decrease in GPO activity that catalyzes the reduction of lipid
peroxides will result in severe cell damage.39 Glutathione is
reduced by GRx to maintain antioxidant activity.40 Therefore,
GRx activity has to be maintained at a specific level to protect
the integrity of the cell against oxidative damage. A mecha-
nism that functions against oxidative stress is GST. This
molecule inactivates hyperperoxides and hydroxy alkalines,
malondialdeydes, and propenals.41 Enzymes such as SOD and
CAT are natural antioxidants that slow the rate of lipid per-
oxidation. Superoxide dismutase protects cells against the
harmful effects of superoxide radicals, whereas CAT directly
neutralizes the H2O2 that increases during oxidative stress.
42
Catalase is more effective in environments where H2O2 is
present in high concentrations.43 In liver tissue, the activities
of GSH, GPO, GRx, GST, SOD, and CATwere higher and the
levels of MDA and NO were lower in the TPPG and NACG
than in the PAG in our study. The data from the literature and
our experiment results indicate that significant oxidative stress
develops in the liver of rats that are administered paracetamol.
The activities of AST, ALT, and LDH in the PAG blood
specimens were significantly higher than in the HG, TPPG,
and NACG blood specimens. In this study, no statistically
significant difference existed between the oxidant and anti-
oxidant parameters in the TPPG and NACG at the doses used.
However, compared to NAC, TPP more effectively reduced
the activity of AST, ALT, and LDH. The most widely accepted
tests used for evaluating liver function are AST, ALT, and
LDH activity assays.44 The activities of these enzymes in-
crease in liver damage.44 This stems particularly from an in-
crease in aminotransferase levels or an excessive increase in
cell membrane permeability.45 Thiamine pyrophosphate re-
duces the severe increase in LDH, AST, ALT, and oxidant
parameters in liver damage caused by methotrexate.33
In conclusion, high-dose paracetamol (i.e., 1000 mg/kg)
altered the oxidant/antioxidant balance in liver tissue in favor
of oxidants. Paracetamol significantly raised the levels of AST,
ALT, and LDH in the rat liver tissue. Thiamine pyrophosphate
and NAC equally prevented paracetamol from changing the
oxidant/antioxidant balance in favor of oxidants. However,
compared to NAC, TPP at a dose of 20 mg/kg more signifi-
cantly reduced the activity of AST, ALT, and LDH. By
contrast, TA failed to protect the liver against oxidative liver
damage induced by paracetamol. These findings show that
TPP can be useful in paracetamol hepatotoxicity.
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